Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
24,183
Sort by:
Immunotherapy Market Forecasts to 2034 – Global Analysis By Therapy Type (Monoclonal Antibodies, Immune Checkpoint Inhibitors, Cancer Vaccines, Cell-based Therapies, Cytokine-based Therapies, Oncolytic Virus Therapy, and Other Therapy Types), Route of Administration, Application, End User, Distribution Channel, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Immunotherapy Market is accounted for $246.3 billion in 2026 and is expected to reach $555.4 billion by 2034 growing at a CAGR of 10.7% during the forecast per...
May 2026
200 pages
Vaccine Market Forecasts to 2034 – Global Analysis By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, mRNA Vaccines, Viral Vector Vaccines, DNA Vaccines, and Combination Vaccines), Valency Type, Disease Indication, Route of Administration, Age Group, Manufacturing Model, Storage & Logistics, End User, Distribution Channel, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Vaccine Market is accounted for $91.4 billion in 2026 and is expected to reach $155.9 billion by 2034 growing at a CAGR of 6.9% during the forecast period. Vac...
May 2026
200 pages
Global Polymyxin B Market Growth 2026-2032
US$ 3,660.00
The global Polymyxin B market size is predicted to grow from US$ 55.37 million in 2025 to US$ 47.60 million in 2032; it is expected to grow at a CAGR of -2.2% from 2026 to 2032. Polymyxin B is a catio...
May 2026
94 pages
Global Meropenem for Injection Market Growth 2026-2032
US$ 3,660.00
The global Meropenem for Injection market size is predicted to grow from US$ 1804 million in 2025 to US$ 2443 million in 2032; it is expected to grow at a CAGR of 4.5% from 2026 to 2032. Meropenem for...
May 2026
96 pages
Global Modified NSAIDs Market Growth 2026-2032
US$ 3,660.00
The global Modified NSAIDs market size is predicted to grow from US$ 7169 million in 2025 to US$ 12144 million in 2032; it is expected to grow at a CAGR of 8.3% from 2026 to 2032. Modified nonsteroida...
May 2026
153 pages
Active Pharmaceutical Ingredient Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Synthesis (Biotech, Fermentation, Plant Extracts, Synthetic), By Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Active Pharmaceutical Ingredient (API) Market is anticipated to expand from USD 160.91 billion in 2025 to USD 241.21 billion by 2031, exhibiting a compound annual growth rate of 6.98%. APIs...
May 2026
177 pages
Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (Bivalent, Quadrivalent, Nonavalent), By Disease (Cervical Cancer, Vaginal and Vulvar Cancers, Anal Cancer, Oropharyngeal (Head and Neck) Cancers, Genital Warts), By Distribution Channel (Hospitals and Retail Pharmacies, Government Suppliers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global market for Human Papillomavirus vaccines is anticipated to expand from USD 8.47 Billion in 2025 to USD 14.12 Billion by 2031, experiencing a compound annual growth rate of 8.89%. HPV vaccin...
May 2026
180 pages
Intravenous Iron Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Iron Dextran, Ferric Gluconate, Iron Sucrose, Ferric Carboxymaltos, Iron Isomaltoside 1000, Ferumoxytol), By Application (Intestinal Malabsorption Syndromes, Inflammatory Diseases, Gastrectomy/Bariatric Surgery, Anemia, Osier-Weber-Rendu Disease, Angiodysplasia, Pregnancy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Intravenous Iron Drugs Market is anticipated to expand from USD 2.55 billion in 2025 to USD 3.57 billion by 2031, reflecting a compound annual growth rate (CAGR) of 5.77%. Administered dire...
May 2026
185 pages
Pharmaceutical & Biopharmaceutical Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Active Pharmaceutical Ingredients (API), Finished Dosage Formulation, Advanced Drug Delivery Products, Over the Counter (OTC) Medicines, Others), By Service (Pharmaceutical Manufacturing Services, Biologics Manufacturing Services, Drug Development Services, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market is projected to grow from USD 14.23 Billion in 2025 to USD 20.43 Billion by 2031 at a 6.21% CAGR. This sector centers on del...
May 2026
188 pages
Digital Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Device Type (Smartphones, Tablets, Others), By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Digital Vaccine Market is anticipated to expand from USD 2.21 Billion in 2025 to USD 3.55 Billion by 2031, reflecting an 8.22% CAGR. A digital vaccine is a software-driven intervention acce...
May 2026
180 pages
Oral Clinical Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Alzheimer’s, Nutritional Deficiencies, Cancer Care, Chronic Kidney Disease, Dysphagia, Others), By Distribution Channel (Direct Sales v/s Indirect Sales), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Oral Clinical Nutrition Market is anticipated to expand from USD 16.96 Billion in 2025 to USD 23.91 Billion by 2031, reflecting a compound annual growth rate of 5.89%. This sector involves...
May 2026
185 pages
Plant Based Excipients Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Carbohydrates, Proteins, Polymers, Minerals, Glycoside & Waxes, Esters, Others), By Application (Binders & Diluents, Glidants, Lubricants & Disintegrants, Film Forming & Coating Agents, Plasticizers, Suspending Agents, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Plant Based Excipients Market is anticipated to expand from USD 2.41 Billion in 2025 to USD 3.11 Billion by 2031, representing a compound annual growth rate (CAGR) of 4.34%. Derived from na...
May 2026
189 pages
Osteoporosis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Route of Administration (Oral, Injectables, Others), By Drug Type (Parathyroid Hormone Therapy, Bisphosphonates, Calcitonin, Selective Estrogen Receptor Modulators, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global market for osteoporosis medications is expected to expand from USD 14.33 billion in 2025 to USD 18.38 billion by 2031, reflecting a compound annual growth rate of 4.24%. These pharmaceutica...
May 2026
180 pages
Contract Research Organization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service (Early Phase Development Services, Clinical Research Services, Laboratory Services, Consulting Services, Data Management Services), By Application (Oncology, Central Nervous System, Cardiovascular, Respiratory, Infectious Diseases, Autoimmune Disorders, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Contract Research Organization (CRO) Market is anticipated to expand from USD 52.72 Billion in 2025 to USD 70.69 Billion by 2031, reflecting a compound annual growth rate of 5.01%. CROs pro...
May 2026
180 pages
Clinical Nutrition Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Route of Administration (Oral, Intravenous), By Nutrition Type (Enteral Nutrition, Parental Nutrition), By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others), By End User (Infant & Child, Adults, Geriatrics), By Substrates (Energy, Carbohydrates, Lipids, Proteins & amino acids, Water & electrolyte, Dietary fiber, Antioxidants), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Clinical Nutrition Market is anticipated to expand from USD 34.09 billion in 2025 to USD 48.38 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.01%. This market involve...
May 2026
180 pages
Coronavirus Vaccine Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV), By Vaccine Type (Virus Vaccine, Viral Vector Vaccine, Nucleic Acid Vaccine, Protein Based Vaccine and Others), By Product Type (Monovalent Vaccine v/s Multivariant Vaccine), By Route of Administration (Intramuscular, Oral, Intranasal), By Patient Type (Adults v/s Pediatric), By End User (Hospitals, Clinics, Research Institutes, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Coronavirus Vaccine Market is anticipated to expand from USD 51.23 billion in 2025 to USD 62.97 billion by 2031, reflecting a compound annual growth rate (CAGR) of 3.5%. These biological pr...
May 2026
185 pages
Remdesivir Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Dosage Form (Lyophilized Solution, Frozen Solution), By Route of Administration (Intravenous, Inhalation), By Patient Age (Geriatric, Adult, Pediatric), By Application (SARS-CoV-2 (COVID-19), MERS-CoV, Ebola, SARS-CoV), By Distribution Channel (Hospitals, Clinics, Drug Stores and Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Remdesivir market is anticipated to expand from USD 4.92 billion in 2025 to USD 7.07 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.23%. Sold under the brand name Vek...
May 2026
180 pages
Contract Research Organization (CRO) Services Market by Type (Early Phase, Clinical, Lab, Consulting), Therapeutic Area [Oncology (Breast, Lung), Infectious, Neurology, Vaccines], Modality, Model (FSO, FSP), End User, Competition - Global Forecast to 2031
US$ 7,150.00
“The Contract Research Organization (CRO) services market is projected to grow at a CAGR of 7.6% between 2018 and 2023.” The CRO services market is expected to reach ... in the CRO services market Service Launch/Innovation: Detailed insights on new service launches in the CRO services market Market Development ...
April 2026
621 pages
Global DTP Vaccine Market Growth 2026-2032
US$ 3,660.00
The global DTP Vaccine market size is predicted to grow from US$ 5747 million in 2025 to US$ 6440 million in 2032; it is expected to grow at a CAGR of 1.6% from 2026 to 2032. The DTP vaccine is a comb...
April 2026
112 pages
Influenza Vaccine Market Size, Share & Trends Analysis Report By Vaccine Type (Inactivated, Live Attenuated), By Indication, By Age Group (Pediatric, Adults), By Route Of Administration (Injection, Nasal Spray), By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global influenza vaccine market size was estimated at USD 8,924.13 million in 2025 and is projected to reach USD 14,797.35 million by 2033, growing at a CAGR of 6.51% from 2026 to 2033. The influe...
April 2026
150 pages
Global Acellular DTP Vaccine Market Growth 2026-2032
US$ 3,660.00
The global Acellular DTP Vaccine market size is predicted to grow from US$ 4310 million in 2025 to US$ 4930 million in 2032; it is expected to grow at a CAGR of 1.9% from 2026 to 2032. Acellular pertu...
April 2026
106 pages
Global Component DTP Vaccine Market Growth 2026-2032
US$ 3,660.00
The global Component DTP Vaccine market size is predicted to grow from US$ 1029 million in 2025 to US$ 1213 million in 2032; it is expected to grow at a CAGR of 2.1% from 2026 to 2032. Component-based...
April 2026
79 pages
Global DPT Series Vaccine Market Growth 2026-2032
US$ 3,660.00
The global DPT Series Vaccine market size is predicted to grow from US$ 5747 million in 2025 to US$ 6440 million in 2032; it is expected to grow at a CAGR of 1.6% from 2026 to 2032. The DTP vaccine is...
April 2026
110 pages
Global Dual GLP-1R/GIPR Agonist Market Growth 2026-2032
US$ 3,660.00
The global Dual GLP-1R/GIPR Agonist market size is predicted to grow from US$ 29966 million in 2025 to US$ 64976 million in 2032; it is expected to grow at a CAGR of 11.6% from 2026 to 2032. In 2025,...
April 2026
94 pages
Global Medical Electrolytes Market Growth 2026-2032
US$ 3,660.00
The global Medical Electrolytes market size is predicted to grow from US$ 11000 million in 2025 to US$ 16900 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032. Medical Electr...
April 2026
139 pages
Excipients Market Size, Share & Trends Analysis Report By Product (Polymers, Alcohols, Sugars, Minerals, Gelatin), By Formulation (Oral, Topical), By Function, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
... also expected to fuel market demand. Polymers dominated the overall market in 2013, accounting for over 45% of global excipient revenues, with growing demand ... has segmented the global excipients market on the basis of product and region: Excipients Product Outlook Polymers MCC (Microcrystalline Cellulose) HPMC ...
April 2026
150 pages
Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, Indication By Study Design, By Service, By Sponsor, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global clinical trials market size is expected to reach USD 68.9 billion by 2026 ... expected to give further boost to the clinical trial market. Worldwide population has varied disease profile ... products North America led the overall clinical trials market in terms of revenue share in 2015 owing to the presence ...
April 2026
150 pages
Clinical Trial Supply & Logistics Market Forecasts to 2034 – Global Analysis By Phase (Phase I, Phase II, Phase III and Phase IV), By Service Type (Logistics & Distribution, Storage & Retention, Packaging, Labeling, and Blinding and Other Service Types), By Therapeutic Area, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Clinical Trial Supply & Logistics Market is accounted for $5.12 billion in 2026 and is expected to reach $10.5 billion by 2034 growing at a CAGR of 9.5% during...
April 2026
200 pages
Drug Discount Card Market Forecasts to 2034 – Global Analysis By Type (Pharmacy Benefit Managers (PBMs), Retail Pharmacy Chains, Direct-to-Consumer Platforms, Non-Profit Organizations and Other Types), By Therapeutic Category (Cardiovascular Drugs, Diabetes Drugs, Pain Medications and Other Therapeutic Categories), By Sales Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Drug Discount Card Market is accounted for $36.0 million in 2026 and is expected to reach $76.1million by 2034 growing at a CAGR of 9.8% during the forecast pe...
April 2026
200 pages
Dupuytren Disease Market Forecasts to 2034 – Global Analysis By Disease Type (Type I, Type II and Type III), Treatment (Needle Aponeurotomy, Surgery, Enzyme Injection, Radiation Therapy, Steroid Shot, Occupational Therapy and Other Treatments), Diagnosis, Route of Administration, Distribution Channel, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Dupuytren Disease Market is accounted for $5.3 billion in 2026 and is expected to reach $8.9 billion by 2034 growing at a CAGR of 6.6% during the forecast peri...
April 2026
200 pages
